Lebsanan

Tacrolimus, the active ingredient in Lebsanan, is a calcineurin inhibitor presented as a topical formulation for skin use. It treats atopic dermatitis and related inflammatory skin conditions in patients requiring localized immunosuppression.

GNH USA supplies Lebsanan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tacrolimus is a topical calcineurin inhibitor used to manage inflammatory skin disorders.

- Atopic dermatitis (mild): improves skin barrier function and reduces itching. - Atopic dermatitis (moderate to severe): controls flare‑ups and decreases lesion formation. - Chronic atopic dermatitis: helps maintain remission and limits new lesion development.

Common Side Effects: - Burning sensation at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or flaking of the skin. - Stinging feeling. - Local skin irritation.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Secondary skin infection. - Severe skin thinning (atrophy). - Systemic immunosuppression (rare). - Lymphoma or other malignancies (very rare).

Precautions for using Lebsanan include: - Avoid application on infected or broken skin: assess lesions before use. - Do not use on open wounds: may increase systemic absorption. - Limit use to prescribed areas: avoid excessive surface coverage. - Monitor for signs of infection: seek medical advice if redness worsens. - Store at room temperature: keep in the original container, protect from moisture and light.

Tacrolimus may interact with other agents as follows:

Major Interactions (Avoid): - Systemic immunosuppressants (e.g., cyclosporine): increased risk of infection. - Live vaccines: reduced vaccine efficacy and potential infection. - Potent topical steroids used concurrently: may enhance systemic exposure.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may affect metabolism. - Macrolide antibiotics (e.g., erythromycin): potential additive immunosuppression. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): monitor for skin irritation.